Additional Information

Description

Ephedrine Sulfate Injection, USP, 50 mg/mL, is a sterile, injectable solution used primarily in clinical settings to manage hypotension and bronchospasm. Ephedrine sulfate, a sympathomimetic agent, exerts its effects by stimulating alpha- and beta-adrenergic receptors, resulting in vasoconstriction and increased cardiac output. This action effectively raises blood pressure and provides relief from bronchial constriction.

Each vial contains 50 mg/mL of ephedrine sulfate, offering a concentrated solution that allows for precise dosing. The injectable form ensures rapid onset of action, which is crucial for managing urgent medical conditions. The solution is typically administered intravenously or intramuscularly, depending on the clinical requirement and patient condition.

Ephedrine sulfate injection is indicated for use in the treatment of severe hypotension, particularly during anesthesia, and for alleviating bronchospasm associated with conditions such as asthma or chronic obstructive pulmonary disease (COPD). Its effectiveness in these applications is due to its dual mechanism of action on adrenergic receptors.